Literature DB >> 25416072

Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.

Johannes Landskron1, Øystein Helland, Knut Martin Torgersen, Einar Martin Aandahl, Bjørn Tore Gjertsen, Line Bjørge, Kjetil Taskén.   

Abstract

Invasive ovarian cancer is associated with poor outcome. The presence of infiltrating regulatory T-cells (Tregs) suppresses protective anti-tumor immune responses, and their accumulation into the tumor microenvironment correlates with reduced survival in ovarian cancer patients. Here, we conducted a detailed characterization of CD4(+) T-cells, CD8(+) T-cells and Treg subsets in the peripheral blood and malignant ascites fluid from seventeen patients with ovarian carcinoma of epithelial origin. Cell distribution, activation status and proliferation status were assessed by multi-color flow cytometry. In ascites fluid, a significant accumulation of CD8(+) cytotoxic T-cells and Tregs was observed compared to peripheral blood. Furthermore, a skewing toward the CD45RA(-) effector/memory compartment was observed in all T-cell subsets in the ascites fluid, but was most pronounced in the Treg population. Regulatory T-cells in the malignant ascites were more activated and had a higher proliferation rate compared to blood-derived cells from the same patient, and their number in ascites was positively correlated with the number of epithelial cells in effusion. In summary, we demonstrate an accumulation of activated CD4(+), CD8(+) and regulatory T-cells in the cancer microenvironment of ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416072     DOI: 10.1007/s00262-014-1636-6

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  33 in total

1.  Sialic Acid-Dependent Inhibition of T Cells by Exosomal Ganglioside GD3 in Ovarian Tumor Microenvironments.

Authors:  Gautam N Shenoy; Jenni Loyall; Charles S Berenson; Raymond J Kelleher; Vandana Iyer; Sathy V Balu-Iyer; Kunle Odunsi; Richard B Bankert
Journal:  J Immunol       Date:  2018-11-16       Impact factor: 5.422

Review 2.  Synthetic biology in cell-based cancer immunotherapy.

Authors:  Deboki Chakravarti; Wilson W Wong
Journal:  Trends Biotechnol       Date:  2015-06-16       Impact factor: 19.536

3.  Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment.

Authors:  Lin-Hui Yang; Li-Zhen Xu; Zhi-Jian Huang; Hong-Hong Pan; Min Wu; Qiu-Yan Wu; Tao Lu; Yan-Ping Zhang; Yao-Bin Zhu; Jia-Bin Wu; Jie-Wei Luo; Guo-Kai Yang; Lie-Fu Ye
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 4.  Friend and foe: the regulation network of ascites components in ovarian cancer progression.

Authors:  Zhe Geng; Xinxing Pan; Juan Xu; Xuemei Jia
Journal:  J Cell Commun Signal       Date:  2022-10-13       Impact factor: 5.908

Review 5.  Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.

Authors:  Militsa Rakina; Anna Kazakova; Alisa Villert; Larisa Kolomiets; Irina Larionova
Journal:  Int J Mol Sci       Date:  2022-06-01       Impact factor: 6.208

Review 6.  Tumor-infiltrating lymphocytes for the treatment of metastatic cancer.

Authors:  M H Geukes Foppen; M Donia; I M Svane; J B A G Haanen
Journal:  Mol Oncol       Date:  2015-10-30       Impact factor: 6.603

7.  VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.

Authors:  Irina V Tiper; Sarah M Temkin; Sarah Spiegel; Simeon E Goldblum; Robert L Giuntoli; Mathias Oelke; Jonathan P Schneck; Tonya J Webb
Journal:  Clin Cancer Res       Date:  2016-04-13       Impact factor: 12.531

8.  Metabolomic characterization of experimental ovarian cancer ascitic fluid.

Authors:  Santosh K Bharti; Flonné Wildes; Chien-Fu Hung; T C Wu; Zaver M Bhujwalla; Marie-France Penet
Journal:  Metabolomics       Date:  2017-08-24       Impact factor: 4.290

Review 9.  The Role of PD-1 Checkpoint Inhibition in Gynecologic Malignancies.

Authors:  Christine Garcia; Kari L Ring
Journal:  Curr Treat Options Oncol       Date:  2018-11-05

Review 10.  Specialized immune responses in the peritoneal cavity and omentum.

Authors:  Mingyong Liu; Aaron Silva-Sanchez; Troy D Randall; Selene Meza-Perez
Journal:  J Leukoc Biol       Date:  2020-09-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.